Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samantha Drennan
Observed names:
Drennan, Samantha,
S Drennan,
S. Drennan,
Samantha Drennan Drennan,
Samantha J Drennan,
Samantha J. Drennan
show all 6
Institutions:
Oxford City Council,
Oxford Spires Academy,
University of Birmingham
Observed institutions:
University of Hull,
Oxford City Council,
Cancer Research UK,
National Institute for Health and Care Research,
NIHR CRUK Experimental Cancer Medicine Centre,
Oxford Spires Academy,
University of Southampton,
Hull York Medical School,
University of Birmingham
show all 9
ORCID:
0000-0002-8993-7806
Observed ORCID:
0000-0002-8993-7806
OpenAlex ID:
A5073100802
Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL
2016
·
Annalisa D’Avola
, Samantha Drennan
, et al.
·
Blood
·
60
PDF
Increased frequency and suppressive activity of CD 127low/− regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement
2013
·
Samantha Drennan
, Nicholas D. Stafford
, et al.
·
Immunology
·
56
IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus
2016
·
S Drennan
, A D'Avola
, et al.
·
Leukemia
·
37
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition
2022
·
Emily X. C. Tye
, Elizabeth Jinks
, et al.
·
Nature Immunology
·
34
PDF
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
2018
·
Samantha Drennan
, Giorgia Chiodin
, et al.
·
Clinical Cancer Research
·
30
PDF
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL
2019
·
Marwan Kwok
, Ceri Oldreive
, et al.
·
Blood
·
28
PDF
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT”
2025
·
Rudolf Stadler
, Gabriele Roccuzzo
, et al.
·
European Journal of Cancer
·
10
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL
2022
·
Giorgia Chiodin
, Samantha Drennan
, et al.
·
Blood Advances
·
9
High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade during Ibrutinib Therapy in CLL Patients
2019
·
Giorgia Chiodin
, David Dutton
, et al.
·
Blood
·
5
Global and MYC-Specific Translation Is Enhanced in Activated Chronic Lymphocytic Leukemia Cells Carrying NOTCH1 C.7541_7542delct Mutations
2016
·
Annalisa D'Avola
, Alison Yeomans
, et al.
·
Blood
·
2
Frequency Over Function: Raised Levels of CD127low/- Regulatory T cells in the Tumour Microenvironment Compared with the Periphery of Head and Neck Cancer Patients
2014
·
Samantha Drennan
·
Journal of Clinical & Cellular Immunology
·
2
PDF
Observing the cancer microenvironment in mycosis fungoides following immune checkpoint blockade
2025
·
Duncan Murray
, Samantha Drennan
, et al.
·
European Journal of Cancer
Abstract 3506: Clinic enabling development of a TCR-Ab half life extended T cell engager against a novel solid tumor target
2025
·
Sarah Leonard
, Hemza Ghadbane
, et al.
·
Cancer Research
Abstract 7438: Mapping T cell reactivity against the human genome using machine learning uncovers target specific TCRs against novel tumour antigens
2025
·
Nathaniel J. Davies
, Amalia Martinez
, et al.
·
Cancer Research
1294 Engineering a T cell receptor (TCR) into an antibody drug format provides a novel approach to half-life extended T cell engagers targeting PRAME A2 and PRAME A24
2024
·
Hemza Ghadbane
, Dominic Hine
, et al.
·
Regular and Young Investigator Award Abstracts
PDF
1206 Profiling the dark genome of tumours provides new potential therapies for cancer patients
2024
·
Nathaniel J Davies
, Samantha Drennan
, et al.
·
Regular and Young Investigator Award Abstracts
Supplementary Tables and Figures from Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
2023
·
Samantha Drennan
, Giorgia Chiodin
, et al.
PDF
Data from Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
2023
·
Samantha Drennan
, Giorgia Chiodin
, et al.
Data from Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
2023
·
Samantha Drennan
, Giorgia Chiodin
, et al.
Supplementary Tables and Figures from Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
2023
·
Samantha Drennan
, Giorgia Chiodin
, et al.
XVIII International Workshop on Chronic Lymphocytic Leukemia 2019
2020
·
Kwok, Marwan Cheng Kuang; id_orcid 0000-0002-3985-5079
, Rawstron, Andy
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Pf526 Structural and Functional Variability of the Tumor B‐cell Receptor Indicates a Role for Environmental Influences on Behavior of Mantle Cell Lymphomas
2019
·
D. Dutton
, G. Chiodin
, et al.
·
HemaSphere
Structural and Functional Variability of the Tumor B-cell Receptor Indicates a Role for Environmental Influences on Behavior of Mantle Cell Lymphomas
2019
·
D. Dutton
, G. Chiodin
, et al.
·
HemaSphere
BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia
2017
·
Marwan Kwok
, Andy C. Rawstron
, et al.
·
Blood
Early Enhancement of IgM Expression and Signaling Capacity during Ibrutinib Therapy in CLL Patients
2016
·
Samantha Drennan
, Giorgia Chiodin
, et al.
·
Blood
Show more works
View as search
Works count:
31
Citation count:
273
H-index:
8
I10-index:
7
Year
Topic
Type
